{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:17:25Z","timestamp":1771928245148,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH385"],"award-info":[{"award-number":["ZR2024QH385"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This retrospective study aimed to evaluate the clinical efficacy of electroconvulsive therapy (ECT) in patients with obsessive-compulsive disorder (OCD) and identify potential predictive factors, focusing on inflammatory markers to optimize therapeutic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed clinical data from 63 OCD patients who received ECT from January 2010 to August 2024. Clinical demographics, ECT parameters, and baseline blood cell counts were extracted from electronic medical records. Inflammatory indices were calculated accordingly. The Clinical Global Impressions-Improvement scale (CGI-I) was utilized to assess treatment outcomes. Patients were categorized into responders and non-responders based on CGI-I scores. Logistic regression analysis determined predictors of ECT efficacy, and the receiver operating characteristic (ROC) curve assessed the predictive capability of these factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 63 patients, 46 (73.0%) responded positively to ECT. Responders had significantly more ECT sessions (\n                      <jats:italic>Z<\/jats:italic>\n                      = - 3.03,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.002), longer seizure durations (\n                      <jats:italic>Z<\/jats:italic>\n                      = -2.40,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.016), and higher baseline neutrophil-to-monocyte ratio (NMR) values (\n                      <jats:italic>T<\/jats:italic>\n                      = 2.76,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.008) compared to non-responders. Logistic regression analysis demonstrated seizure duration was independently associated with efficacy (\n                      <jats:italic>OR<\/jats:italic>\n                      = 1.206,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.019), while baseline NMR did not achieve statistical significance in the multivariate analysis (\n                      <jats:italic>OR<\/jats:italic>\n                      = 1.264,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.063). ROC analysis indicated that seizure duration has significant predictive capability (\n                      <jats:italic>AUC<\/jats:italic>\n                      = 0.696; sensitivity 63.0%, specificity 71.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ECT is clinically effective for OCD, seizure duration was significantly associated with treatment outcomes. Although baseline NMR was not statistically significant in multivariate analysis, it holds potential predictive value, possibly limited by sample size and study design. Future larger-scale, prospective studies are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1715406","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:12:01Z","timestamp":1769674321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Electroconvulsive therapy for obsessive-compulsive disorder: clinical efficacy and predictive role of inflammatory markers"],"prefix":"10.3389","volume":"16","author":[{"given":"Shengkang","family":"Hu","sequence":"first","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]},{"name":"Jining Key Laboratory of Neuromodulation","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]},{"name":"Jining Key Laboratory of Neuromodulation","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiyuan","family":"Fu","sequence":"additional","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]},{"name":"Jining Key Laboratory of Neuromodulation","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]},{"name":"Jining Key Laboratory of Neuromodulation","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Daizhuang Hospital","place":["Jining, Shandong, China"]},{"name":"Jining Key Laboratory of Neuromodulation","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive\u2013compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B2","first-page":"896","article-title":"Obsessive-compulsive disorder diagnosis and management","volume":"92","author":"Fenske","year":"2015","journal-title":"Am Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2014.05.006","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr Clinics North America"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01356.x","article-title":"Issues in the pharmacological treatment of obsessive-compulsive disorder","volume":"61","author":"Math","year":"2007","journal-title":"Int J Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-110122-110434","article-title":"Deep brain stimulation for obsessive-compulsive disorder and depression","volume":"46","author":"Sheth","year":"2023","journal-title":"Annu Rev Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2023.12.010","article-title":"Deep brain stimulation for obsessive-compulsive disorder: optimal stimulation sites","volume":"96","author":"Meyer","year":"2024","journal-title":"Biol Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5152\/alphapsychiatry.2024.231473","article-title":"Efficacy of modified electroconvulsive therapy in treatment-resistant schizophrenia","volume":"25","author":"Chen","year":"2024","journal-title":"A Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.32598\/bcn.2022.3524.1","article-title":"The therapeutic effect of electroconvulsive therapy in patients with obsessive-compulsive disorder: A quasi-experimental study","volume":"14","author":"Noorazar","year":"2023","journal-title":"Basc Clin Neurosci J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2021.37","article-title":"Electroconvulsive therapy for depression: 80 years of progress","volume":"219","author":"Kirov","year":"2021","journal-title":"Br J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.10.005","article-title":"Effect of modified electroconvulsive therapy on neuro metabolites and magnetic resonance spectroscopy imaging signals in patients with refractory obsessive-compulsive disorder","volume":"296","author":"Liu","year":"2022","journal-title":"J Affect Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-019-1062-8","article-title":"Obsessive-compulsive disorder: autoimmunity and neuroinflammation","volume":"21","author":"Gerentes","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8606057","article-title":"Microglial dysregulation in OCD, tourette syndrome, and PANDAS","volume":"2016","author":"Frick","year":"2016","journal-title":"J Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3358","article-title":"Layer V cortical neurons require microglial support for survival during postnatal development","volume":"16","author":"Ueno","year":"2013","journal-title":"Nat Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer Dorothy","year":"2012","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nn1629","article-title":"Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood","volume":"9","author":"Ziv Y","year":"2006","journal-title":"Nat Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3641","article-title":"Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior","volume":"17","author":"Zhan","year":"2014","journal-title":"Nat Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137028","article-title":"Electroconvulsive stimulation attenuates chronic neuroinflammation","volume":"5","author":"Goldfarb","year":"2020","journal-title":"JCI Insight"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120936538","article-title":"The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies","volume":"34","author":"Giacobbe","year":"2020","journal-title":"J Psychopharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X0903700509","article-title":"Comparison between the effects of propofol and etomidate on motor and electroencephalogram seizure duration during electroconvulsive therapy","volume":"37","author":"Tan","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1797","article-title":"Approaches to denote treatment outcome: Clinical significance and clinical global impression compared","volume":"28","author":"De Beurs","year":"2019","journal-title":"Int J Methods Psychiatr Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.18330","article-title":"Association of clinical and demographic characteristics with response to electroconvulsive therapy in mania","volume":"5","author":"Popiolek","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/jcm10091924","article-title":"Neutrophil-to-lymphocyte ratio, a novel inflammatory marker, as a predictor of bipolar type in depressed patients: A quest for biological markers","volume":"10","author":"Dionisie","year":"2021","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2018.03.012","article-title":"Neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in mood disorders: A meta-analysis","volume":"84","author":"Mazza","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab088","article-title":"Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: A randomized, open-label, non-inferiority trial (KetECT)","volume":"25","author":"Ekstrand","year":"2022","journal-title":"Int J Neuropsychol Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1040443","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study","volume":"13","author":"Li","year":"2022","journal-title":"Front Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14r09129","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder","volume":"76","author":"Fontenelle","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.18r02342","article-title":"A systematic review of the utility of electroconvulsive therapy in broadly defined obsessive-compulsive\u2013related disorders","volume":"20","author":"Dos Santos-Ribeiro","year":"2018","journal-title":"Prim Care Compan For CNS Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.15","article-title":"Improvement in both severe obsessive\u2013compulsive disorder and refractory tardive dystonia following electroconvulsive therapy: A case report","volume":"1","author":"Mihara","year":"2022","journal-title":"Psychiatry Clin Neurosci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000731","article-title":"Electroconvulsive therapy in refractory obsessive-compulsive disorder: A case report","volume":"37","author":"Martins-Correia","year":"2021","journal-title":"J ECT"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000660","article-title":"Electroconvulsive therapy in treatment-resistant obsessive-compulsive disorder comorbid with major depressive disorder A series of 3 cases","volume":"36","author":"Chiu CH","year":"2020","journal-title":"J ECT"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2019.02.015","article-title":"Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression","volume":"12","author":"Vanicek","year":"2019","journal-title":"Brain Stimul"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-018-0924-0","article-title":"Brain serotonin critically contributes to the biological effects of electroconvulsive seizures","volume":"268","author":"Kronenberg","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.genhosppsych.2023.04.015","article-title":"Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis","volume":"83","author":"Wang","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15622975.2022.2058083","article-title":"BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis","volume":"24","author":"Pelosof","year":"2022","journal-title":"World J Biol Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5152\/alphapsychiatry.2022.0003","article-title":"Biomolecular research on electroconvulsive therapy for mental disorders: state of the art and future directions","volume":"23","author":"Cavaleri","year":"2022","journal-title":"A Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2006.02.003","article-title":"Immunology of obsessive-compulsive disorder","volume":"29","author":"Murphy","year":"2006","journal-title":"Psychiatr Clinics North America"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0184-19.2019","article-title":"The behavioral sequelae of social defeat require microglia and are driven by oxidative stress in mice","volume":"39","author":"Lehmann","year":"2019","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/627325","article-title":"Microglia: an active player in the regulation of synaptic activity","volume":"2013","author":"Ji","year":"2013","journal-title":"Neural Plasticity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/608654","article-title":"Microglial dysregulation in psychiatric disease","volume":"2013","author":"Frick","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.08.032","article-title":"Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures","volume":"59","author":"Wennstr\u00f6m","year":"2006","journal-title":"Biol Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00228-6","article-title":"Increased neurogenesis in a model of electroconvulsive therapy","volume":"47","author":"Madsen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J Psychiatr Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/syn.21518","article-title":"Electroconvulsive seizures stimulate the vegf pathway via mTORC1","volume":"66","author":"Elfving","year":"2011","journal-title":"Synapse"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2009.07.001","article-title":"Immunohistochemical evaluation of the protein expression of nerve growth factor and its TrkA receptor in rat limbic regions following electroshock seizures","volume":"65","author":"Conti","year":"2009","journal-title":"Neurosci Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00266-X","article-title":"The effects of repeated minimal electroconvulsive shock exposure on levels of mRNA encoding fibroblast growth factor-2 and nerve growth factor in limbic regions","volume":"114","author":"Kondratyev A","year":"2002","journal-title":"Neuroscience"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-016-0094-x","article-title":"Potential mechanisms underlying the therapeutic effects of electroconvulsive therapy","volume":"33","author":"Jiang","year":"2017","journal-title":"Neurosci Bull"},{"key":"B49","doi-asserted-by":"publisher","first-page":"115708","DOI":"10.1016\/j.jpsychires.2024.05.048","article-title":"The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy","volume":"332","author":"Wang","year":"2024","journal-title":"Psychiatry Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.06.040","article-title":"Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study","volume":"256","author":"Carlier","year":"2019","journal-title":"J Affect Disord"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11597","article-title":"Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression","volume":"79","author":"Kruse","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.22738","article-title":"Seizure duration and electroconvulsive therapy in major depressive disorder","volume":"7","author":"Gillving","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/00124509-200203000-00015","article-title":"The practice of electroconvulsive therapy recommendations for treatment, training, and privileging (second edition)","volume":"18","author":"Rasmussen","year":"2002","journal-title":"J ECT"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(78)90086-X","article-title":"Seizure duration and clinical effect in electroconvulsive therapy","volume":"19","author":"Maletzky","year":"1978","journal-title":"Compr Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/YCT.0000000000000716","article-title":"Factors associated with seizure adequacy along the course of electroconvulsive therapy","volume":"37","author":"Tedeschi","year":"2021","journal-title":"J ECT"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2021.07.007","article-title":"The effects of anesthetic change on electrographic seizure duration during electroconvulsive therapy","volume":"14","author":"Luccarelli","year":"2021","journal-title":"Brain Stimul"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2024.03.044","article-title":"An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis","volume":"173","author":"Ramakrishnan","year":"2024","journal-title":"J Psychiatr Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1715406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:26:15Z","timestamp":1771925175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1715406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":57,"alternative-id":["10.3389\/fpsyt.2025.1715406"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1715406","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1715406"}}